Schizophrenia - Nursing Case Study
Pathophysiology
• Primary mechanism: Dopamine Dysregulation - Schizophrenia is primarily associated with an imbalance in dopamine neurotransmission, particularly hyperactivity in the mesolimbic pathway leading to positive symptoms (e.g., hallucinations) and hypoactivity in the mesocortical pathway contributing to negative symptoms (e.g., apathy).
• Secondary mechanism: Glutamate Dysfunction - Reduced function of NMDA receptors on GABAergic interneurons disrupts glutamatergic signaling, affecting cognitive functions and exacerbating both positive and negative symptoms.
• Key complication: Neurodevelopmental Abnormalities - Structural brain changes, including enlarged ventricles and reduced gray matter, are observed, suggesting a neurodevelopmental component that may be influenced by genetic and environmental factors, complicating diagnosis and treatment.
Patient Profile
Demographics:
29-year-old male, software engineer
History:
• Key past medical history: Diagnosed with schizophrenia 2 years ago, history of moderate depression
• Current medications: Risperidone 3 mg daily, Sertraline 50 mg daily
• Allergies: No known drug allergies
Current Presentation:
• Chief complaint: Increased auditory hallucinations and social withdrawal
• Key symptoms: Hearing voices, lack of motivation, difficulty concentrating, occasional paranoia
• Vital signs: Blood pressure 146/92 mmHg, heart rate 102 bpm, temperature 98.6°F, respiratory rate 18 breaths per minute
Section 1
Change in Patient Status:
After several weeks of consistent medication adherence, the patient presents to the outpatient clinic with a noted deterioration in his condition. Despite being on Risperidone and Sertraline, he reports an increase in the intensity and frequency of auditory hallucinations and has begun experiencing new visual hallucinations. He describes seeing shadows and fleeting figures at the periphery of his vision, which has heightened his paranoia. His social withdrawal has become more pronounced, as he has stopped attending work and avoids interacting with friends and family. The patient’s lack of motivation and difficulty concentrating have also worsened, making daily activities increasingly challenging.
During the clinical assessment, the nurse observes that the patient appears disheveled and displays a flat affect. His blood pressure is elevated at 150/94 mmHg, and his heart rate remains tachycardic at 105 bpm, indicating potential side effects or stress-related responses. A mental status examination reveals a disorganized thought process and impaired insight, as the patient struggles to articulate his experiences coherently. Given these changes, the healthcare team considers the potential for treatment resistance or the need for medication adjustment, exploring options such as increasing the dosage of current medications or considering an alternative antipsychotic. Additionally, the impact of potential stressors, non-adherence to therapy, or substance use that could exacerbate symptoms is also reviewed.
The clinical team decides to consult with a psychiatrist for a comprehensive evaluation and possible modification of the treatment regimen. They also plan to conduct a thorough review of the patient’s support system and explore therapeutic interventions, such as cognitive behavioral therapy, to address both the positive and negative symptoms. This evolving situation requires careful monitoring of the patient's mental health status, adherence to medication, and any environmental or lifestyle factors that may contribute to his condition.
Section 2
The psychiatrist conducts a comprehensive evaluation, noting the patient's increased distress and symptomatology despite adherence to the prescribed medication regimen. During this assessment, the psychiatrist orders a series of diagnostic tests, including a complete blood count, metabolic panel, and drug screening, to rule out metabolic imbalances or substance use that could be contributing to the patient's deteriorating mental state. The results reveal elevated liver enzymes and a slight increase in prolactin levels, likely side effects of the Risperidone. The patient's weight has also increased by 8 pounds since the last visit, raising concerns about metabolic syndrome, a known risk with certain antipsychotics.
Given these findings, the psychiatrist recommends transitioning the patient to Aripiprazole, an antipsychotic with a lower risk of metabolic side effects and prolactin elevation. Additionally, the healthcare team initiates a plan to gradually taper the Risperidone while introducing Aripiprazole at a low dose, monitoring the patient closely for any adverse reactions or improvements in symptoms. The psychiatrist also emphasizes the importance of regular follow-up appointments to assess the patient's response to the new medication and to make further adjustments as necessary.
To address the patient's heightened paranoia and social withdrawal, the team integrates cognitive behavioral therapy sessions into the treatment plan, focusing on strategies to manage hallucinations and improve social engagement. The nurse collaborates with the patient to identify potential stressors and enhance coping mechanisms, such as relaxation techniques and establishing a structured daily routine. These multifaceted interventions aim to stabilize the patient's condition and foster a gradual return to functional daily living, with ongoing evaluation of progress and challenges guiding subsequent treatment decisions.
Section 3
Two weeks after the initiation of Aripiprazole and tapering of Risperidone, the patient returns for a follow-up appointment. The initial assessment reveals a slight improvement in the patient's paranoia, as they report fewer instances of feeling watched or followed. However, they continue to experience auditory hallucinations, though the intensity has somewhat diminished. During the physical examination, the nurse notes that the patient's blood pressure is 138/88 mmHg, slightly elevated from their baseline. Their weight remains stable, with no further gains since the last visit. The patient expresses frustration over persistent fatigue and difficulty concentrating, which they attribute to the ongoing medication transition.
Laboratory results from the most recent tests show a favorable trend, with liver enzyme levels beginning to normalize, indicating a positive response to the medication change. However, a new concern arises as the patient's fasting blood glucose level is noted at 110 mg/dL, suggesting the onset of glucose intolerance. The psychiatrist discusses these findings with the patient, emphasizing the need for lifestyle modifications to prevent further metabolic complications. The treatment plan is adjusted to include dietary counseling and an exercise regimen tailored to the patient's capabilities and preferences.
In response to these developments, the healthcare team intensifies its effort to address the patient's social withdrawal and cognitive challenges. Cognitive behavioral therapy sessions are increased to twice weekly to reinforce coping strategies and address the patient's residual symptoms. The nurse continues to work closely with the patient, encouraging adherence to the new lifestyle changes and monitoring for any signs of distress or adverse reactions to the medication shift. This comprehensive approach seeks to balance the management of both psychiatric symptoms and metabolic health, aiming for a holistic improvement in the patient's quality of life.
Section 4
Two weeks following the implementation of dietary counseling and the initiation of an exercise regimen, the patient returns for another follow-up appointment. During the initial assessment, the nurse observes that the patient's weight has decreased by 2 pounds, a positive indication of adherence to lifestyle changes. However, the patient reports experiencing increased episodes of dizziness and lightheadedness, particularly when standing up quickly. Upon measuring the patient's orthostatic blood pressures, the nurse notes a significant drop: the sitting blood pressure is 120/80 mmHg, which falls to 108/72 mmHg upon standing. These findings suggest the development of orthostatic hypotension, potentially linked to the patient's increased physical activity and adjustments in medication.
In light of these new symptoms, the psychiatrist orders a comprehensive metabolic panel and a re-evaluation of the patient's current medication dosages. The laboratory results reveal that the patient's fasting blood glucose has improved slightly to 105 mg/dL, indicating a positive response to dietary modifications. However, the sodium level is at the lower end of the normal range at 136 mmol/L, prompting consideration of potential hyponatremia. In response, the healthcare team adjusts the exercise plan to include more gradual transitions between positions and emphasizes the importance of adequate hydration and balanced electrolyte intake.
The nurse educates the patient on recognizing the signs of orthostatic hypotension and advises them to rise slowly from sitting or lying positions. Meanwhile, the cognitive behavioral therapy sessions continue to yield progress, as the patient reports a slight improvement in concentration and a reduction in auditory hallucination frequency. The team remains vigilant in monitoring these developments, aiming to fine-tune the balance between managing schizophrenia symptoms and mitigating emerging complications. As the patient's journey unfolds, the focus remains on a holistic approach to care, ensuring both psychiatric stability and physical well-being.
Section 5
As the patient's treatment progresses, a follow-up visit is scheduled to reassess the response to the adjusted interventions. During this appointment, the nurse conducts a comprehensive assessment and notes that the patient appears more alert and engaged in conversation. Vital signs are recorded with a seated blood pressure of 118/78 mmHg, but on standing, there is still a noticeable drop to 110/70 mmHg, indicating persistent yet slightly improved orthostatic hypotension. The heart rate remains stable at 78 beats per minute, and the respiratory rate is 16 breaths per minute, suggesting no immediate signs of respiratory distress.
The patient reports feeling less dizzy but admits to experiencing occasional muscle cramps, especially during the night. This symptom, along with the recent laboratory finding of low-normal sodium levels, prompts the healthcare team to consider the possibility of an electrolyte imbalance, potentially exacerbated by increased physical activity and insufficient dietary sodium intake. The psychiatrist decides to conduct a more detailed electrolyte panel, which reveals a further slight decrease in sodium to 134 mmol/L, reinforcing the suspicion of mild hyponatremia.
In response to these findings, the care plan is adjusted to include dietary counseling focused on increasing sodium intake safely, and recommendations for electrolyte-rich fluids are provided. The exercise regimen is modified to incorporate more frequent breaks and exercises that minimize rapid positional changes. The nursing staff continues to educate the patient on self-monitoring for signs of dehydration and electrolyte imbalance, emphasizing the importance of maintaining a consistent fluid and nutrient intake. The team remains proactive in adjusting the treatment plan, ensuring that the patient's schizophrenia remains well-managed while addressing these emerging physical health concerns. As the patient continues to navigate the complexities of managing both schizophrenia and its associated complications, the healthcare team remains committed to a holistic and adaptive approach to care.